Keyword: Guardant Health

In its IPO filing, Guardant Health disclosed it had received a cyberattack, with hackers accessing the personal information of about 1,100 patients.

Cancer blood test maker Guardant Health plans to go public, filing an IPO on the Nasdaq using the symbol GH.

SoftBank is considering a $150 million investment in siteless trial runner Science 37, the latest in a string of biotech deals, according to reports.

Genomics, bioelectronics and artificial intelligence are clear themes among FierceMedTech's 2017 Fierce 15 companies.

Guardant Health filed suit against Foundation Medicine in a U.S. District Court in California for false advertising and unfair competition.

Guardant Health has raised $360 million to sequence the tumor DNA of 1 million cancer patients in the next five years.

Freenome has raised $65 million in a round led by Andreessen Horowitz to put its cancer-detection tests through more rigorous trials.

Guardant Health and the University of Texas MD Anderson Cancer Center aim to to push liquid biopsy into the standard of care in cancer treatment.